MedTrace Logo

Cognitive Training in Parkinson Study

NCT02920632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

This study evaluates the efficacy of an eight-week online cognitive training program on objective and subjective cognitive functions in Parkinson's disease. Moreover, we intend to map the effect on brain network function, and if cognitive training can prevent the development of PD-MCI/PD-D after one- and two-year follow-up. In this study, two training groups will be compared (N: 70 vs 70). In a part of the participants MRI will be assessed (N: 40 vs. 40). We expect cognitive training to improve cognitive functions, and to improve the efficiency of brain network function. Moreover, we expect that cognitive training can decrease the risk of PD-MCI/PD-D at one- and two-year follow-up.

Conditions

  • Parkinson Disease
  • Impaired Cognition
  • Alteration in Cognition

Interventions

BEHAVIORAL

Online cognitive training 1

Eight-week online cognitive training program, three times a week for 45 minutes. The training contains several games that are designed to train cognitive functions.

BEHAVIORAL

Online cognitive training 2

Eight-week online active comparator program, three times a week for 45 minutes. The training contains several games.

Sponsors & Collaborators

  • Dutch Parkinson Patient Association

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Chris Vriend, PhD. · Amsterdam UMC, location VUmc

  • Odile A Van den Heuvel, MD PhD. · Amsterdam UMC, location VUmc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2019-07-17
Completion
2021-08-09

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920632 on ClinicalTrials.gov